Objectives: This study describes the health technology assessment (HTA) framework introduced by Regione Lombardia to regulate the introduction of new technologies. The study outlines the process and dimensions adopted to prioritize, assess and appraise the requests of new technologies. Methods: The HTA framework incorporates and adapts elements from the EUnetHTA Core Model and the EVIDEM framework. It includes dimensions, topics, and issues provided by EUnetHTA Core Model to collect data and process the assessment. Decision making is instead supported by the criteria and Multi-Criteria Decision Analysis technique from the EVIDEM consortium. Results: The HTA framework moves along three process stages: (i) prioritization of requests, (ii) assessment of prioritized technology, (iii) appraisal of technology in support of decision making. Requests received by Regione Lombardia are first prioritized according to their relevance along eight dimensions (e.g., costs, efficiency and efficacy, organizational impact, safety). Evidence about the impacts of the prioritized technologies is then collected following the issues and topics provided by EUnetHTA Core Model. Finally, the Multi-Criteria Decision Analysis technique is used to appraise the novel technology and support Regione Lombardia decision making. Conclusions: The VTS (Valutazione delle Tecnologie Sanitarie) framework has been successfully implemented at the end of 2011. From its inception, twenty-six technologies have been processed.
机构:
F Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, SwitzerlandF Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, Switzerland
Gyldmark, Marlene
Lampe, Kristian
论文数: 0引用数: 0
h-index: 0
机构:
Independent HTA Expert, Canberra, ACT, AustraliaF Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, Switzerland
Lampe, Kristian
Ruof, Joerg
论文数: 0引用数: 0
h-index: 0
机构:
R Connect GmbH, Basel, SwitzerlandF Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, Switzerland
Ruof, Joerg
Pohlmann, Johannes
论文数: 0引用数: 0
h-index: 0
机构:
Ossian Hlth Econ & Commun, Basel, SwitzerlandF Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, Switzerland
Pohlmann, Johannes
Hebborn, Ansgar
论文数: 0引用数: 0
h-index: 0
机构:
F Hoffmann La Roche, Global Market Access Policy, Basel, SwitzerlandF Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, Switzerland
Hebborn, Ansgar
Kristensen, Finn Borlum
论文数: 0引用数: 0
h-index: 0
机构:
Univ Southern Denmark, Fac Hlth Sci, Odense, DenmarkF Hoffmann La Roche, MORSE Hlth Technol Assessment Grp, Pharmaceut Div Global Pricing & Market Access, Basel, Switzerland